Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and XaJoanne M Smallheer, Richard S Alexander, Jianmin Wang, et al.Clinical Journal of the American Society of Nephrology : CJASN|April 26, 2014
Clinical and economic outcomes associated with medication errors in kidney transplantationDavid J Taber, Justin R Spivey, Victoria M Tsurutis, et al.JMIR Research Protocols|September 6, 2013
Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled TrialJohn W McGillicuddy, Mathew J Gregoski, Anna K Weiland, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
3,3-Bisaryloxindoles as mineralocorticoid receptor antagonistsDavid A Neel, Matthew L Brown, Peter A Lander, et al.Plos One|January 26, 2024
Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent modelsXiaojun Wang, Xiaohong Yu, Kostas Gavardinas, et al.Journal of the American College of Surgeons|February 2, 2023
Multilevel Intervention to Improve Racial Equity in Access to Kidney TransplantDavid J Taber, Zemin Su, Mulugeta Gebregziabher, et al.Pediatric Transplantation|November 19, 2015
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipientsCameron L Jordan, David J Taber, Maggee O Kyle, et al.Clinical Transplantation|April 22, 2016
Predicting and preventing readmissions in kidney transplant recipientsKelly L Covert, James N Fleming, Carmelina Staino, et al.ACS Medicinal Chemistry Letters|October 15, 2014
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic AneurysmPrabhakar K Jadhav, Matthew A Schiffler, Kostas Gavardinas, et al.Journal of Medicinal Chemistry|November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptorMichael G Bell, Douglas L Gernert, Timothy A Grese, et al.Pageof 14